Biomarkers in Vestibular Schwannoma–Associated Hearing Loss

Vestibular schwannomas (VSs) are benign tumors composed of differentiated neoplastic Schwann cells. They can be classified into two groups: sporadic VS and those associated with neurofibromatosis type 2 (NF2). VSs usually grow slowly, initially causing unilateral sensorineural hearing loss (HL) and...

Full description

Bibliographic Details
Published in:Frontiers in Neurology
Main Authors: Luis Lassaletta, Miryam Calvino, Jose Manuel Morales-Puebla, Pablo Lapunzina, Lourdes Rodriguez-de la Rosa, Isabel Varela-Nieto, Victor Martinez-Glez
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Subjects:
vestibular schwannoma
neurofibromatosis type 2
biomarkers
hearing loss
perilymph
chemokine
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00978/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.00978/full

Similar Items